JoVE Logo

Zaloguj się

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

5.3K Views

07:17 min

January 29th, 2021

DOI :

10.3791/62033-v

January 29th, 2021


Przeglądaj więcej filmów

Murine Ommaya Model

Rozdziały w tym wideo

0:04

Introduction

1:07

Injection of CTCs into CSF to Generate a Mouse LMD Model

3:37

Murine Ommaya Assembly and Implantation

5:20

Results: Direct-Targeted Immunotherapy Using the Murine Ommaya Increases the Overall Survival of Breast Cancer-Associated Leptomeningeal Disease Mice

6:37

Conclusion

Powiązane Filmy

article

08:11

A Simple Guide Screw Method for Intracranial Xenograft Studies in Mice

23.1K Views

article

08:02

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model

16.3K Views

article

05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

6.7K Views

article

07:37

Translational Orthotopic Models of Glioblastoma Multiforme

2.6K Views

article

04:01

Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

1.5K Views

article

11:14

Creating Anatomically Accurate and Reproducible Intracranial Xenografts of Human Brain Tumors

15.6K Views

article

06:25

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

761 Views

article

09:10

An Immunocompetent Murine Model for Laser Interstitial Thermal Therapy of Glioblastoma

339 Views

article

11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

7.8K Views

article

01:38

Chirurgiczne wstrzyknięcie Cisterna Magna: metoda podawania komórek nowotworowych bezpośrednio do ośrodkowego układu nerwowego modelu mysiego

5.8K Views

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone